118156-93-7 Usage
Description
1-BOC-3-PIPERIDINECARBOXALDEHYDE, also known as N-Boc-3-piperidinecarboxaldehyde, is an organic compound that serves as a crucial intermediate in the synthesis of various pharmaceuticals and chemicals. It is characterized by its colorless liquid appearance and plays a significant role in the development of new compounds with potential applications in different industries.
Uses
Used in Pharmaceutical Industry:
1-BOC-3-PIPERIDINECARBOXALDEHYDE is used as an organic chemical synthesis intermediate for the development of new pharmaceutical compounds. Its unique structure allows for the creation of a wide range of drugs with potential therapeutic applications, including those targeting central nervous system disorders, pain management, and other medical conditions.
Used in Chemical Industry:
1-BOC-3-PIPERIDINECARBOXALDEHYDE is also utilized as a key intermediate in the synthesis of various chemicals, such as agrochemicals, dyes, and other specialty chemicals. Its versatility in chemical reactions enables the production of a diverse array of products with specific properties and applications in different sectors.
Check Digit Verification of cas no
The CAS Registry Mumber 118156-93-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,8,1,5 and 6 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 118156-93:
(8*1)+(7*1)+(6*8)+(5*1)+(4*5)+(3*6)+(2*9)+(1*3)=127
127 % 10 = 7
So 118156-93-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H19NO3/c1-11(2,3)15-10(14)12-6-4-5-9(7-12)8-13/h8-9H,4-7H2,1-3H3
118156-93-7Relevant articles and documents
(E) and (Z)-3-styrylpiperidines as sigma ligands
Mantegani, Sergio,Brambilla, Enzo,Cremonesi, Paolo,Caccia, Carla,Fornaretto, Maria Gioia,Carfagna, Nicola,Colombo, Monica,McArthur, Robert A.,Varasi, Mario
, p. 1525 - 1530 (1997)
A class of (E) and Q-3-styrylpiperidine derivatives was prepared as racemates and evaluated for affinity at σ binding sites labeled with [3H]-(±-SKF-10,047. Some of these compounds exhibited high affinity and selectivity for σ verus D1 and D2 binding sites.
NOVEL HISTONE METHYLTRANSFERASE INHIBITORS
-
Page/Page column 30; 34, (2021/04/01)
The present invention relates to novel compounds of formula (I) as defined herein. The compounds are inhibitors of histone methyltransferases of the seven-beta-strand family, in particular of KMT9.
A kind of protease inhibitor and its preparation and use
-
Paragraph 0027-0029, (2018/03/25)
The invention discloses a kind of protease inhibitors, and preparation method and application thereof. The invention discloses a kind of compounds and pharmaceutical compositions thereof, and a preparation method and application thereof. The invention relates to a kind of compounds capable of reducing or inhibiting activity of dual leucine zipper kinase in cells or a subject, and application of the compounds, or solvates, hydrates or medicinal salts thereof to prevent or treat patient diseases or related diseases caused by abnormity of dual leucine zipper kinase.